# Wendy's Co: financial statements, quarterly

WEN · Nasdaq · CIK 30697 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/wen.md) · [Financials](/companies/wen/financials.md) · [Filings](/companies/wen/filings.md) · [Insiders](/companies/wen/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wen/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [551](/filings/0000030697-24-000018.md) | [541 d](/filings/0000030697-26-000009.md) | [535](/filings/0000030697-25-000006.md) | [571](/filings/0000030697-25-000010.md) | [567](/filings/0000030697-25-000039.md) | [574 d](/filings/0000030697-26-000009.md) | [523](/filings/0000030697-26-000060.md) | [561](/filings/0000030697-26-000116.md) | [550](/filings/0000030697-25-000039.md) | [543 d](/filings/0000030697-26-000009.md) | [541](/filings/0000030697-26-000060.md) | [571](/filings/0000030697-26-000116.md) |
| Cost of revenue | $m | [200](/filings/0000030697-24-000018.md) | [197 d](/filings/0000030697-26-000009.md) | [192](/filings/0000030697-25-000006.md) | [200](/filings/0000030697-25-000010.md) | [196](/filings/0000030697-25-000039.md) | [196 d](/filings/0000030697-26-000009.md) | [188](/filings/0000030697-26-000060.md) | [197](/filings/0000030697-26-000116.md) | [204](/filings/0000030697-25-000039.md) | [203 d](/filings/0000030697-26-000009.md) | [201](/filings/0000030697-26-000060.md) | [207](/filings/0000030697-26-000116.md) |
| Operating income | $m | [102](/filings/0000030697-24-000018.md) | [86.6 d](/filings/0000030697-26-000009.md) | [81.2](/filings/0000030697-25-000006.md) | [99.5](/filings/0000030697-25-000010.md) | [94.7](/filings/0000030697-25-000039.md) | [96.0 d](/filings/0000030697-26-000009.md) | [83.1](/filings/0000030697-26-000060.md) | [104](/filings/0000030697-26-000116.md) | [92.0](/filings/0000030697-25-000039.md) | [64.0 d](/filings/0000030697-26-000009.md) | [64.9](/filings/0000030697-26-000060.md) | [79.3](/filings/0000030697-26-000116.md) |
| Interest expense | $m | [31.0](/filings/0000030697-23-000013.md) | [30.3 d](/filings/0000030697-24-000004.md) | [30.5](/filings/0000030697-24-000009.md) | [31.0](/filings/0000030697-24-000012.md) | [31.3](/filings/0000030697-25-000039.md) | [31.1 d](/filings/0000030697-26-000009.md) | [31.5](/filings/0000030697-26-000060.md) | [30.9](/filings/0000030697-26-000116.md) | [31.5](/filings/0000030697-25-000039.md) | [32.5 d](/filings/0000030697-26-000009.md) | [34.1](/filings/0000030697-26-000060.md) | [33.9](/filings/0000030697-26-000116.md) |
| Income tax | $m | [19.9](/filings/0000030697-24-000018.md) | [20.4 d](/filings/0000030697-26-000009.md) | [15.5](/filings/0000030697-25-000006.md) | [20.2](/filings/0000030697-25-000010.md) | [19.4](/filings/0000030697-25-000039.md) | [23.0 d](/filings/0000030697-26-000009.md) | [15.7](/filings/0000030697-26-000060.md) | [20.8](/filings/0000030697-26-000116.md) | [19.0](/filings/0000030697-25-000039.md) | [6.7 d](/filings/0000030697-26-000009.md) | [11.5](/filings/0000030697-26-000060.md) | [16.0](/filings/0000030697-26-000116.md) |
| Net income | $m | [58.0](/filings/0000030697-24-000018.md) | [46.9 d](/filings/0000030697-26-000009.md) | [42.0](/filings/0000030697-25-000039.md) | [54.6](/filings/0000030697-25-000039.md) | [50.2](/filings/0000030697-25-000039.md) | [47.5 d](/filings/0000030697-26-000009.md) | [39.2](/filings/0000030697-26-000116.md) | [55.1](/filings/0000030697-26-000116.md) | [44.3](/filings/0000030697-25-000039.md) | [26.5 d](/filings/0000030697-26-000009.md) | [22.7](/filings/0000030697-26-000116.md) | [32.6](/filings/0000030697-26-000116.md) |
| Diluted EPS | $ per share | [0.28](/filings/0000030697-24-000018.md) | not reported | [0.20](/filings/0000030697-25-000006.md) | [0.27](/filings/0000030697-25-000010.md) | [0.25](/filings/0000030697-25-000039.md) | not reported | [0.19](/filings/0000030697-26-000060.md) | [0.29](/filings/0000030697-26-000116.md) | [0.23](/filings/0000030697-25-000039.md) | not reported | [0.12](/filings/0000030697-26-000060.md) | [0.17](/filings/0000030697-26-000116.md) |
| Basic EPS | $ per share | [0.28](/filings/0000030697-24-000018.md) | not reported | [0.20](/filings/0000030697-25-000006.md) | [0.27](/filings/0000030697-25-000010.md) | [0.25](/filings/0000030697-25-000039.md) | not reported | [0.20](/filings/0000030697-26-000060.md) | [0.29](/filings/0000030697-26-000116.md) | [0.23](/filings/0000030697-25-000039.md) | not reported | [0.12](/filings/0000030697-26-000060.md) | [0.17](/filings/0000030697-26-000116.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [598](/filings/0000030697-23-000013.md) | [516](/filings/0000030697-26-000009.md) | [498](/filings/0000030697-24-000009.md) | [465](/filings/0000030697-24-000012.md) | [482](/filings/0000030697-24-000018.md) | [451](/filings/0000030697-26-000009.md) | [335](/filings/0000030697-25-000006.md) | [281](/filings/0000030697-25-000010.md) | [291](/filings/0000030697-25-000039.md) | [301](/filings/0000030697-26-000116.md) | [299](/filings/0000030697-26-000060.md) | [341](/filings/0000030697-26-000116.md) |
| Current assets | $m | [926](/filings/0000030697-23-000013.md) | [838](/filings/0000030697-25-000003.md) | [868](/filings/0000030697-24-000009.md) | [791](/filings/0000030697-24-000012.md) | [783](/filings/0000030697-24-000018.md) | [736](/filings/0000030697-26-000009.md) | [644](/filings/0000030697-25-000006.md) | [600](/filings/0000030697-25-000010.md) | [641](/filings/0000030697-25-000039.md) | [618](/filings/0000030697-26-000116.md) | [652](/filings/0000030697-26-000060.md) | [678](/filings/0000030697-26-000116.md) |
| Total assets | $m | [5,290](/filings/0000030697-23-000013.md) | [5,183](/filings/0000030697-25-000003.md) | [5,190](/filings/0000030697-24-000009.md) | [5,088](/filings/0000030697-24-000012.md) | [5,073](/filings/0000030697-24-000018.md) | [5,035](/filings/0000030697-26-000009.md) | [4,919](/filings/0000030697-25-000006.md) | [4,894](/filings/0000030697-25-000010.md) | [4,976](/filings/0000030697-25-000039.md) | [4,957](/filings/0000030697-26-000116.md) | [4,925](/filings/0000030697-26-000060.md) | [4,884](/filings/0000030697-26-000116.md) |
| Current liabilities | $m | [405](/filings/0000030697-23-000013.md) | [382](/filings/0000030697-25-000003.md) | [425](/filings/0000030697-24-000009.md) | [365](/filings/0000030697-24-000012.md) | [373](/filings/0000030697-24-000018.md) | [398](/filings/0000030697-26-000009.md) | [434](/filings/0000030697-25-000006.md) | [415](/filings/0000030697-25-000010.md) | [794](/filings/0000030697-25-000039.md) | [351](/filings/0000030697-26-000116.md) | [356](/filings/0000030697-26-000060.md) | [357](/filings/0000030697-26-000116.md) |
| Total liabilities | $m | [4,948](/filings/0000030697-23-000013.md) | [4,873](/filings/0000030697-25-000003.md) | [4,896](/filings/0000030697-24-000009.md) | [4,814](/filings/0000030697-24-000012.md) | [4,813](/filings/0000030697-24-000018.md) | [4,775](/filings/0000030697-26-000009.md) | [4,789](/filings/0000030697-25-000006.md) | [4,781](/filings/0000030697-25-000010.md) | [4,867](/filings/0000030697-25-000039.md) | [4,839](/filings/0000030697-26-000116.md) | [4,809](/filings/0000030697-26-000060.md) | [4,764](/filings/0000030697-26-000116.md) |
| Long-term debt | $m | [2,768](/filings/0000030697-23-000013.md) | [2,733](/filings/0000030697-25-000003.md) | [2,727](/filings/0000030697-24-000009.md) | [2,722](/filings/0000030697-24-000012.md) | [2,716](/filings/0000030697-24-000018.md) | [2,662](/filings/0000030697-26-000009.md) | [2,657](/filings/0000030697-25-000006.md) | [2,651](/filings/0000030697-25-000010.md) | [2,299](/filings/0000030697-25-000039.md) | [2,731](/filings/0000030697-26-000116.md) | [2,725](/filings/0000030697-26-000060.md) | [2,719](/filings/0000030697-26-000116.md) |
| Current portion of debt | $m | [29.3](/filings/0000030697-23-000013.md) | [29.3](/filings/0000030697-25-000003.md) | [29.3](/filings/0000030697-24-000009.md) | [29.3](/filings/0000030697-24-000012.md) | [29.3](/filings/0000030697-24-000018.md) | [78.2](/filings/0000030697-26-000009.md) | [78.3](/filings/0000030697-25-000006.md) | [78.5](/filings/0000030697-25-000010.md) | [425](/filings/0000030697-25-000039.md) | [29.8](/filings/0000030697-26-000116.md) | [29.8](/filings/0000030697-26-000060.md) | [29.8](/filings/0000030697-26-000116.md) |
| Shareholders' equity | $m | [343](/filings/0000030697-24-000018.md) | [310](/filings/0000030697-26-000009.md) | [294](/filings/0000030697-25-000039.md) | [274](/filings/0000030697-25-000039.md) | [260](/filings/0000030697-25-000039.md) | [259](/filings/0000030697-26-000116.md) | [130](/filings/0000030697-26-000116.md) | [113](/filings/0000030697-26-000116.md) | [109](/filings/0000030697-25-000039.md) | [117](/filings/0000030697-26-000116.md) | [116](/filings/0000030697-26-000116.md) | [120](/filings/0000030697-26-000116.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [128 d](/filings/0000030697-24-000018.md) | [75.9 d](/filings/0000030697-26-000009.md) | [100.0](/filings/0000030697-25-000006.md) | [45.5 d](/filings/0000030697-25-000010.md) | [141 d](/filings/0000030697-25-000039.md) | [68.6 d](/filings/0000030697-26-000009.md) | [85.4](/filings/0000030697-26-000060.md) | [60.6 d](/filings/0000030697-26-000116.md) | [129 d](/filings/0000030697-25-000039.md) | [69.3 d](/filings/0000030697-26-000009.md) | [59.4](/filings/0000030697-26-000060.md) | [101 d](/filings/0000030697-26-000116.md) |
| Capital expenditure | $m | [25.5 d](/filings/0000030697-24-000018.md) | [29.3 d](/filings/0000030697-26-000009.md) | [17.4](/filings/0000030697-25-000006.md) | [17.1 d](/filings/0000030697-25-000010.md) | [17.9 d](/filings/0000030697-25-000039.md) | [42.0 d](/filings/0000030697-26-000009.md) | [17.7](/filings/0000030697-26-000060.md) | [21.4 d](/filings/0000030697-26-000116.md) | [25.0 d](/filings/0000030697-25-000039.md) | [37.9 d](/filings/0000030697-26-000009.md) | [11.9](/filings/0000030697-26-000060.md) | [19.6 d](/filings/0000030697-26-000116.md) |
| Dividends paid | $m | [52.2 d](/filings/0000030697-24-000018.md) | [51.4 d](/filings/0000030697-26-000009.md) | [51.4](/filings/0000030697-25-000006.md) | [51.3 d](/filings/0000030697-25-000010.md) | [50.8 d](/filings/0000030697-25-000039.md) | [51.0 d](/filings/0000030697-26-000009.md) | [49.4](/filings/0000030697-26-000060.md) | [26.8 d](/filings/0000030697-26-000116.md) | [26.7 d](/filings/0000030697-25-000039.md) | [26.6 d](/filings/0000030697-26-000009.md) | [26.6](/filings/0000030697-26-000060.md) | [26.7 d](/filings/0000030697-26-000116.md) |
| Share repurchases | $m | [55.5 d](/filings/0000030697-24-000018.md) | [47.1 d](/filings/0000030697-26-000009.md) | [7.3](/filings/0000030697-25-000006.md) | [27.0 d](/filings/0000030697-25-000010.md) | [25.8 d](/filings/0000030697-25-000039.md) | [17.3 d](/filings/0000030697-26-000009.md) | [123](/filings/0000030697-26-000060.md) | [63.7 d](/filings/0000030697-26-000116.md) | [14.3 d](/filings/0000030697-25-000039.md) | [0.0 d](/filings/0000030697-26-000009.md) | [0.0](/filings/0000030697-26-000060.md) | [1.9 d](/filings/0000030697-26-000116.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [215](/filings/0000030697-23-000013.md) | [215](/filings/0000030697-24-000009.md) | [213](/filings/0000030697-24-000012.md) | [211](/filings/0000030697-24-000018.md) | [207](/filings/0000030697-25-000006.md) | [206](/filings/0000030697-25-000010.md) | [204](/filings/0000030697-25-000039.md) | [202](/filings/0000030697-26-000060.md) | [193](/filings/0000030697-26-000116.md) | [191](/filings/0000030697-25-000039.md) | [191](/filings/0000030697-26-000060.md) | [191](/filings/0000030697-26-000116.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 190,669,930 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000030697-26-000116.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.